论文部分内容阅读
目的探讨利凡诺引产前应用米非司酮配伍和单纯行利凡诺羊膜腔注射引产的临床效果,从而改善单一应用利凡诺中期引产的并发症,减轻患者痛苦。方法选择80例应用口服米非司酮加羊膜腔注射利凡诺组与单纯应用利凡诺羊膜腔注射组80例进行对照。结果两组引产成功率、产后出血量差异无统计学意义(P>0.05),两组宫缩发动时间、总产程时间差异有统计学意义(P<0.01),两组胎盘、胎膜残留率比较差异无统计学意义(P>0.05)。结论米非司酮配伍利凡诺羊膜腔注射用于中期引产可以加快产程进展,缩短宫缩发动时间及总产程时间。出血少,安全性高,不良反应少。
Objective To investigate the clinical effect of rivanol in combination with mifepristone and rivanol amniotic fluid injection before induction of labor, so as to improve the complications of single-dose rivanopril mid-term induction of labor and alleviate the suffering of patients. Methods 80 cases of oral administration of mifepristone plus amiodarone plus rivanol group and simple application of rivanol amniotic cavity injection group of 80 patients for comparison. Results There was no significant difference between the two groups in the success rate of induction of labor and the amount of postpartum hemorrhage (P> 0.05). There was significant difference between the two groups in the time of onset of contractions and in the duration of labor (P <0.01) The difference was not statistically significant (P> 0.05). Conclusion Mifepristone combined with Rivanol amniotic cavity injection for mid-term induction of labor can speed up the progress of labor, shorten the time of uterine contractions and the duration of labor. Less bleeding, high safety, fewer adverse reactions.